Comparison

BRL-54443 European Partner

Item no. S2852-1000
Manufacturer Selleckchem
CASRN 57477-39-1
Amount 1 g
Quantity options 10 mg 1 g 10 g 10 mM/1 ml 50 mg 5 g
Category
Type Inhibitors
Specific against other
Smiles CN1CCC(CC1)C2=CNC3=C2C=C(C=C3)O
ECLASS 10.1 32160490
ECLASS 11.0 32160490
UNSPSC 12000000
Alias 5-HT1E,5-HT1F,5-HT1A,5-HT1B,5-HT1D,5-HT Receptor
Similar products BRL
Available
Storage Conditions
2 years -80 in solvent
Molecular Weight
230, 31
Administration
s.c.
Animal Models
Adult male cats
Dosages
3 ug/kg-30 mg/kg
Formulation
Distilled water containing 1 equivalent 2, 3-dihydroxybutanedioic acid+0.9% NaCl
IC50
8.7 (pKi), 8.7 (pKi), 8.7 (pKi), 8.7 (pKi), 8.7 (pKi), 8.7 (pKi)
In vitro
BRL 54443 has also measurable affinity for the 5-HT2A receptor. BRL 54443 induces contraction with a logEC50 of 6.52. Contraction caused by BRL 54443 is likely mediated through stimulation of 5-HT5-HT2A receptors. [2]
In vivo
BRL 54443 induces an immediate dose-dependent maximal intragastric volume increase vs. saline. [1]
Kinase Assay
Membrane preparation and binding assay, The binding affinity of a set of 5-HT receptor agonists and antagonists (samples) at 5-HT1F receptors is tested. To do this h5-HT1F-HEK 293 cells are cultured in Petri dishes till 90% confluency is reached. The cells are scraped from the plates and suspended in 50 mM Tris–HCl buffer (pH 7.4). After centrifugation (23, 500, g) the pellet is suspended in 5 mM Tris–HCl buffer (pH 7.4) and homogenized with an Ultra Turrax homogeniser. The membranes are collected by centrifugation at 18, 000, g for 20 minutes, resuspended in 50 mM Tris–HCl (pH 7.4) and stored at 80 C. At the day of the binding experiment, the membranes are defrosted and homogenized. The protein concentration is determined using the Bradford protein assay and the membranes are diluted in the assay buffer down to 65 ug protein/mL (50 mM Tris–HCl, 10 mM MgCl2, 1 mM EGTA and 10 uM pargyline, pH 7.4). Assay mixtures (0.5 mL) contained 0.4 mL membrane preparation and 2 nM of tritiated 5-HT (118 Ci/mmol), mine the non-specific binding 1 uM sumatriptan is added. Per sample studied 15 mixtures are created containing different concentrations (10 uM–1 pM) of the sample. The mixtures are then incubated for 60 minutes at 25 C (protected from light), incubation is stopped by rapid filtration on a Filtermate 96. Bound radioactivity is determined by liquid scintillation counting. Data are analysed graphically with inhibition curves and IC50 values are derived. Ki values are calculated according to the equation Ki =IC50/(1+(C/Kd)), with C as the concentration of [3H]5-HT (2 nM) and Kd as the equilibrium dissociation constant of [3H]5-HT (2.61 nM).
Solubility (25C)
DMSO 46 mg/mL, Water <1 mg/mL, Ethanol 2 mg/mL
Information
BRL 54443 is a 5-HT1E and 5-HT1F receptor agonist with pKi of 8.7 and 9.25, respectively, with a weak binding affinity for 5-HT1A, 5-HT1B, 5-HT1D receptors.
Chemical Name
1H-Indol-5-ol, 3-(1-methyl-4-piperidinyl)-

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 1 g
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?